Skip to main content
Clinical Trials/NL-OMON35044
NL-OMON35044
Completed
Not Applicable

Treatment of peri-implant mucositis; A randomized placebo controlled clinical study - Treatment of peri-implant mucositis

niversitair Medisch Centrum Groningen0 sites30 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
infection of mucosa surrounding a dental implant
Sponsor
niversitair Medisch Centrum Groningen
Enrollment
30
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\) The patient is \>\=18 years of age;
  • 2\) The patient has at least one endosseous implant in the oral cavity with clinical signs of peri\-implant mucositis. Peri\-implant mucositis is defined as bleeding of the peri\-implant mucosa on probing, with no signs of loss of supporting bone;
  • 3\) The implants have been exposed to the oral environment for at least one year;
  • 4\) The patient is capable of understanding and giving informed consent.

Exclusion Criteria

  • 1\) Medical and general contraindications for the interventions;
  • 2\) A history of local radiotherapy to the head and neck region;
  • 3\) Diabetes;
  • 4\) Patients who are allergic to chlorhexidine;
  • 5\) Systemic use of antibiotics during the last 3 months;
  • 6\) Long\-term use of anti\-inflammatory drugs;
  • 7\) Incapability of performing basal oral hygiene measures as a result of physical or mental disorders;
  • 8\) Active, uncontrolled periodontal pathology of the remaining dentition.
  • 9\) Local use of antibiotics or use of other anti\-septic / antimicrobial therapies in the oral cavity during the last 3 months;
  • 10\) Use of mouthrinses during the last 6 weeks or during the course of the study;

Outcomes

Primary Outcomes

Not specified

Similar Trials